Nath K A, Grande J P, Haggard J J, Croatt A J, Katusic Z S, Solovey A, Hebbel R P
Nephrology Research Unit, Mayo Clinic/Foundation, 200 First St. SW, 542 Guggenheim Bldg., Rochester, MN 55905, USA.
Am J Pathol. 2001 Mar;158(3):893-903. doi: 10.1016/S0002-9440(10)64037-0.
Chronic nephropathy is a recognized complication of sickle cell disease. Using a transgenic sickle mouse, we examined whether oxidative stress occurs in the sickle kidney, the origins and functional significance of such oxidant stress, and the expression of the oxidant-inducible, potentially protective gene, heme oxygenase-1 (HO-1); we also examined the expression of HO-1 in the kidney and in circulating endothelial cells in sickle patients. We demonstrate that this transgenic sickle mouse exhibits renal enlargement, medullary congestion, and a reduced plasma creatinine concentration. Oxidative stress is present in the kidney as indicated by increased amounts of lipid peroxidation; heme content is markedly increased in the kidney. Exacerbation of oxidative stress by inhibiting glutathione synthesis with buthionine-sulfoximine dramatically increased red blood cell sickling in the sickle kidney: in buthionine-sulfoximine-treated sickle mice, red blood cell sickling extended from the medulla into the cortical capillaries and glomeruli. HO activity is increased in the sickle mouse kidney, and is due to induction of HO-1. In the human sickle kidney, HO-1 is induced in renal tubules, interstitial cells, and in the vasculature. Expression of HO-1 is increased in circulating endothelial cells in patients with sickle cell disease. These results provide the novel demonstration that oxidative stress occurs in the sickle kidney, and that acute exacerbation of oxidative stress in the sickle mouse precipitates acute vaso-occlusive disease. Additionally, the oxidant-inducible, heme-degrading enzyme, HO-1, is induced regionally in the murine and human sickle kidney, and systemically, in circulating endothelial cells in sickle patients.
慢性肾病是镰状细胞病公认的并发症。我们利用转基因镰状小鼠,研究了镰状肾中是否发生氧化应激、这种氧化应激的起源和功能意义,以及氧化应激诱导型潜在保护基因血红素加氧酶-1(HO-1)的表达;我们还研究了镰状细胞病患者肾脏和循环内皮细胞中HO-1的表达。我们证明,这种转基因镰状小鼠表现出肾脏肿大、髓质充血和血浆肌酐浓度降低。脂质过氧化增加表明肾脏存在氧化应激;肾脏中的血红素含量显著增加。用丁硫氨酸-亚砜亚胺抑制谷胱甘肽合成可加剧氧化应激,从而显著增加镰状肾中的红细胞镰变:在丁硫氨酸-亚砜亚胺处理的镰状小鼠中,红细胞镰变从髓质延伸至皮质毛细血管和肾小球。镰状小鼠肾脏中的HO活性增加,这是由HO-1的诱导所致。在人类镰状肾中,肾小管、间质细胞和脉管系统中均诱导表达HO-1。镰状细胞病患者循环内皮细胞中HO-1的表达增加。这些结果首次证明镰状肾中存在氧化应激,并且镰状小鼠中氧化应激的急性加剧会引发急性血管闭塞性疾病。此外,氧化应激诱导型血红素降解酶HO-1在小鼠和人类镰状肾中呈区域性诱导表达,在镰状细胞病患者的循环内皮细胞中呈全身性诱导表达。